A

Anika Therapeutics

ANIK

26.150
USD
-1.09
(-4.00%)
Market Closed
Volume
1,171
EPS
0
Div Yield
0
P/E
-5
Market Cap
364,739,296
Related Instruments
C
CNMD
-3.750
(-5.42%)
65.390 USD
EW
-1.220
(-1.94%)
61.830 USD
I
IART
-0.160
(-0.65%)
24.630 USD
ISRG
6.98
(1.57%)
451.27 USD
M
MMSI
-1.240
(-1.45%)
84.110 USD
N
NUVA
-0.720
(-1.77%)
39.980 USD
O
OSUR
0.01000
(0.22%)
4.50000 USD
P
PODD
2.950
(1.52%)
197.390 USD
SYK
5.59
(1.71%)
332.94 USD
Z
ZBH
-0.280
(-0.25%)
111.100 USD
News

Title: Anika Therapeutics

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Anika Therapeutics Inc is an orthopedic medicines company. It is committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions with clinically meaningful therapies. The company focuses on orthopedics, including osteoarthritis pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies. Geographically, it derives a majority of its revenue from the United States.